Table 3.

Percentage (95% CI) positive agreement between the macimorelin GHST and the ITT at different cutpoints among participants with a positive finding for each ITT cutpoint.

Macimorelin cutpoint, ng/mL	ITT cutpoint, ng/mL
	2.8 (n = 62/140)	4.0 (n = 67/140)	5.1 (n = 74/140)	6.5 (n = 82/140)
2.8	87.1% (76.2–94.3%)	80.6% (69.1–89.2%)	74.3% (62.8–83.8%)	68.3% (57.1–78.1%)
4.0	88.7% (78.1–95.3%)	82.1% (70.8–90.4%)	78.4% (67.3–87.1%)	72.0% (60.9–81.3%)
5.1	90.3% (80.1–96.4%)	86.6% (76.0–93.7%)	82.4% (71.8–90.3%)	75.6% (64.9–84.4%)
6.5	93.6% (84.3–98.2%)	89.6% (79.7–95.7%)	87.8% (78.2–94.3%)	81.7% (71.6–89.4%)

Results in italics are based on using the same cutpoints for macimorelin and the ITT. n = number of participants with a positive finding using the specified ITT cutpoint.

GHST, growth hormone stimulation test; ITT, insulin tolerance test.